Sarah Li Selected Research

Neoplasms (Cancer)

10/2016

ERα-XPO1 Cross Talk Controls Tamoxifen Sensitivity in Tumors by Altering ERK5 Cellular Localization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarah Li Research Topics

Disease

2	COVID-19 01/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 10/2016 - 01/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Viremia 01/2022
1	Cross Infection (Nosocomial Infection) 01/2020
1	Gingivitis 10/2017
1	Hemorrhage 10/2017
1	Neoplasms (Cancer) 10/2016
1	Aspergillosis 10/2008
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2006

Drug/Important Bio-Agent (IBA)

2	Indicators and Reagents (Reagents)IBA 10/2017 - 10/2016
1	AntibodiesIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	VaccinesIBA 01/2020
1	Dentifrices (Dentifrice)IBA 10/2017
1	Estrogen ReceptorsIBA 10/2016
1	selinexorIBA 10/2016
1	Tamoxifen FDA LinkGeneric 10/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014
1	Docetaxel (Taxotere)FDA Link 01/2014
1	Taxoids (Taxanes)IBA 01/2014
1	Toll-Like Receptor 4IBA 10/2008
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 10/2006

Therapy/Procedure

2	Therapeutics 01/2020 - 10/2016
1	Personal Protective Equipment 01/2020
1	Stem Cell Transplantation 10/2008